Iannetta, M., Landi, D., Cola, G., Malagnino, V., Teti, E., Fraboni, D., et al. (2021). T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers. MULTIPLE SCLEROSIS AND RELATED DISORDERS.
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers
Iannetta M;Landi D;Malagnino V;Teti E;Buccisano F;Grelli S;Andreoni M;Marfia G;Sarmati L
2021-08-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.